Authors : Tanmay Jape; Ayesha Fatima Syeda; Moin Akhtar Shaik; Prasanth Hanumanthu; Najah Fathima

Volume/Issue : Volume 10 - 2025, Issue 7 - July

Google Scholar : https://tinyurl.com/bdz6t7f2

Scribd : https://tinyurl.com/457mnvxx

DOI : https://doi.org/10.38124/ijisrt/25jul1885

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Patients with acute myocardial infarction (AMI) may show no blockage in their coronary arteries. This condition is known as myocardial infarction with non-obstructive coronary arteries (MINOCA). It affects between 6–8% of individuals with spontaneous MI who are referred for coronary angiography screening. The key mechanisms responsible are coronary artery spasm, thrombosis, and atherosclerosis. Identifying the underlying mechanism of infarction determines how MINOCA is managed. A systematic approach for the diagnosis is recommended. Diagnostic yield is achieved by combining cardiac magnetic resonance imaging, provocative testing for coronary spasm, multivessel intracoronary imaging, and invasive coronary angiography. Majority of the practice guidelines and treatment regimens are currently based on data from patients with MI with obstructive coronary artery disease (MI-CAD) and secondary prevention guidelines for atherosclerotic disease. The risk of long-term adverse outcomes remains high for MINOCA patients. Hence, in order to determine the best course of treatment for patients with MINOCA, more clinical trials are needed. This review emphasizes the pathophysiology of MINOCA, highlighting its various causes, challenges in diagnosis, the need for personalized treatment, and the necessity for further research on clinical outcomes.

Keywords : MINOCA; Atherosclerosis; Coronary Arteries; Coronary Angiography; Cardiac Magnetic Resonance

References :

1. J. P. Collet, H. Thiele, E. Barbato, O. Barthélémy, J. Bauersachs, D. L. Bhatt, P. Dendale, M. Dorobantu, T. Edvardsen, T. Folliguet, C. P. Gale, M. Gilard, A. Jobs, P. Jüni, E. Lambrinou, B. S. Lewis, J. Mehilli, E. Meliga, B. Merkely, C. Mueller, et al., “2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation,” Eur. Heart J., vol. 42, no. 14, pp. 1289–1367, 2021. doi: 10.1093/eurheartj/ehaa575.
2. J. E. Tamis-Holland, H. Jneid, H. R. Reynolds, et al., “Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association,” Circulation, vol. 139, pp. e891–e908, 2019. doi: 10.1161/CIR.0000000000000670.
3. A. Redondo-Diéguez, R. Gonzalez-Ferreiro, E. Abu-Assi, S. Raposeiras-Roubin, O. Aidhodjayeva, A. López-López, M. Castiñeira-Busto, C. Peña-Gil, J. M. García-Acuña, and J. R. González-Juanatey, “Long-term prognosis of patients with non-ST-segment elevation acute myocardial infarction and coronary arteries without significant stenosis,” Rev. Esp. Cardiol. (Engl Ed), vol. 68, pp. 777–784, 2015. doi: 10.1016/j.rec.2014.09.022.
4. A. N. Cheema, B. Yanagawa, S. Verma, A. Bagai, and S. Liu, “Myocardial infarction with nonobstructive coronary artery disease (MINOCA): a review of pathophysiology and management,” Curr. Opin. Cardiol., vol. 36, no. 5, pp. 589–596, Sept. 2021. doi: 10.1097/HCO.0000000000000886.
5. A. Khan, A. Lahmar, M. Riasat, et al., “Myocardial infarction with non-obstructive coronary arteries: an updated overview of pathophysiology, diagnosis, and management,” Cureus, vol. 14, 2022. doi: 10.7759/cureus.23602.
6. B. Safdar, E. S. Spatz, R. P. Dreyer, J. F. Beltrame, J. H. Lichtman, J. A. Spertus, et al., “Presentation, clinical profile, and prognosis of young patients with myocardial infarction with nonobstructive coronary arteries (MINOCA): results from the VIRGO study,” J. Am. Heart Assoc., vol. 7, 2018. doi: 10.1161/JAHA.118.009174.
7. S. Pasupathy, T. Air, R. P. Dreyer, R. Tavella, and J. F. Beltrame, “Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries,” Circulation, vol. 131, pp. 861–870, 2015. doi: 10.1161/CIRCULATIONAHA.114.011201.
8. L. L. H. De Oliveira, V. M. Correia, P. F. G. Nicz, P. R. Soares, and T. L. Scudeler, “MINOCA: One size fits all? Probably not—A review of etiology, investigation, and treatment,” J. Clin. Med., vol. 11, no. 19, p. 5497, 2022. doi: 10.3390/jcm11195497.
9. E. Khattab, D. Karelas, T. Pallas, P. Kostakis, C. H. Papadopoulos, S. Sideris, N. Patsourakos, and N. P. E. Kadoglou, “MINOCA: A pathophysiological approach of diagnosis and treatment—A narrative review,” Biomedicines, vol. 12, no. 11, p. 2457, 2024. doi: 10.3390/biomedicines12112457.
10. D. Sacks, B. Baxter, B. C. V. Campbell, J. S. Carpenter, C. Cognard, D. Dippel, M. Eesa, U. Fischer, K. Hausegger, J. A. Hirsch, M. S. Hussain, O. Jansen, M. V. Jayaraman, A. A. Khalessi, B. W. Kluck, S. Lavine, P. M. Meyers, S. Ramee, D. A. Rüfenacht, et al., “Multisociety Consensus Quality Improvement Revised Consensus Statement for Endovascular Therapy of Acute Ischemic Stroke,” Int. J. Stroke, vol. 13, no. 6, pp. 612–632, 2018. doi: 10.1177/1747493018778713.
11. F. Pelliccia, C. J. Pepine, C. Berry, and P. G. Camici, “The role of a comprehensive two-step diagnostic evaluation to unravel the pathophysiology of MINOCA: A review,” Int. J. Cardiol., vol. 336, pp. 1–7, 2021. doi: 10.1016/j.ijcard.2021.05.045.
12. M. Yildiz, N. Ashokprabhu, A. Shewale, M. Pico, T. D. Henry, and O. Quesada, “Myocardial infarction with non-obstructive coronary arteries (MINOCA),” Front. Cardiovasc. Med., vol. 9, 2022. doi: 10.3389/fcvm.2022.1032436.
13. S. Iwańczyk, P. Woźniak, A. Araszkiewicz, M. Grygier, A. Klotzka, and M. Lesiak, “Optical coherence tomography in the diagnosis of myocardial infarction with non-obstructive coronary arteries,” Adv. Interv. Cardiol., vol. 18, no. 3, pp. 192–200, 2022. doi: 10.5114/aic.2022.121233.
14. J. E. Tamis-Holland and H. Jneid, “Myocardial infarction with nonobstructive coronary arteries (MINOCA): It’s time to face reality!,” J. Am. Heart Assoc., vol. 7, no. 13, 2018. doi: 10.1161/jaha.118.009635.
15. S. Edpuganti, “Fungal endocarditis: microbial insights, diagnostic and therapeutic challenges in the modern era,” Explor. Cardiol., vol. 3, p. 101264, 2025. doi: 10.37349/ec.2025.101264.
16. S. Edpuganti, K. S. Thomas, S. S. A. Ponnuri, R. K. Tomar, and P. H. Kapuge, “Obesity and metabolic syndrome: Pathophysiological mechanisms driving cardiovascular risk,” Junior Researchers, vol. 3, no. 3, pp. 20–35, 2025. doi: 10.52340/jr.2025.03.03.03.
17. P. Yang, S. Zhang, X. Yin, Y. Zhang, H. Zhu, Y. Cao, and C. Shen, “Myocardial infarction with nonobstructive coronary arteries (MINOCA): A narrative review,” Eur. J. Med. Res., vol. 30, no. 1, 2025. doi: 10.1186/s40001-025-02703-3.
18. H. Bakhshi and C. M. Gibson, “MINOCA: Myocardial infarction no obstructive coronary artery disease,” Am. Heart J. Plus, vol. 33, p. 100312, 2023. doi: 10.1016/j.ahjo.2023.100312.
19. P. Parwani, N. Kang, M. Safaeipour, M. A. Mamas, J. Wei, M. Gulati, S. S. Naidu, and N. B. Merz, “Contemporary diagnosis and management of patients with MINOCA,” Curr. Cardiol. Rep., vol. 25, no. 6, pp. 561–570, 2023. doi: 10.1007/s11886-023-01874-x.
20. I. I. R. Candelario, A. E. Perez-Aybar, and J. A. Roman-Ramos, “MINOCA: A working diagnosis,” Cureus, 2023. doi: 10.7759/cureus.49695.
21. R. Rinaldi, G. Princi, G. La Vecchia, A. Bonanni, G. Chiarello, A. Candreva, F. Gragnano, P. Calabrò, F. Crea, and R. Montone, “MINOCA associated with a myocardial bridge: Pathogenesis, diagnosis and treatment,” J. Clin. Med., vol. 12, no. 11, p. 3799, 2023. doi: 10.3390/jcm12113799.
22. A. M. Nordenskjöld, S. Agewall, D. Atar, T. Baron, J. Beltrame, O. Bergström, D. Erlinge, C. P. Gale, J. López-Pais, T. Jernberg, P. Johansson, A. Ravn-Fisher, H. R. Reynolds, J. B. Somaratne, P. Tornvall, and B. Lindahl, “Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design,” Am. Heart J., vol. 231, pp. 96–104, 2021. doi: 10.1016/j.ahj.2020.10.059.
23. P. Paolisso, L. Bergamaschi, G. Saturi, E. C. D'Angelo, I. Magnani, S. Toniolo, A. Stefanizzi, A. Rinaldi, L. Bartoli, F. Angeli, F. Donati, P. Rucci, A. V. Mattioli, N. Taglieri, C. Pizzi, and N. Galiè, “Secondary prevention medical therapy and outcomes in patients with myocardial infarction with non-obstructive coronary artery disease,” Front. Pharmacol., vol. 10, p. 1606, 2020. doi: 10.3389/fphar.2019.01606.
24. A. M. Nordenskjöld, B. Lagerqvist, T. Baron, T. Jernberg, N. Hadziosmanovic, H. R. Reynolds, P. Tornvall, and B. Lindahl, “Reinfarction in patients with myocardial infarction with nonobstructive coronary arteries (MINOCA): Coronary findings and prognosis,” Am. J. Med., vol. 132, no. 3, pp. 335–346, 2019. doi: 10.1016/j.amjmed.2018.10.007.
25. J. Saw, K. Humphries, E. Aymong, T. Sedlak, R. Prakash, A. Starovoytov, and G. B. J. Mancini, “Spontaneous coronary artery dissection: Clinical outcomes and risk of recurrence,” J. Am. Coll. Cardiol., vol. 70, pp. 1148–1158, 2017. doi: 10.1016/j.jacc.2017.06.053.
26. B. Lindahl, T. Baron, D. Erlinge, et al., “Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease,” Circulation, vol. 135, pp. 1481–1489, 2017. doi: 10.1161/CIRCULATIONAHA.116.026336.
27. C. Kovach, A. Hebbe, C. I. O’Donnell, M. E. Plomondon, P. L. Hess, A. Rahman, S. Mulukutla, S. W. Waldo, and J. A. Valle, “Comparison of patients with nonobstructive coronary artery disease with versus without myocardial infarction (from the VA Clinical Assessment Reporting and Tracking [CART] Program),” Am. J. Cardiol., vol. 146, pp. 1–7, 2021. doi: 10.1016/j.amjcard.2021.01.015.
28. G. Ciliberti, M. Verdoia, M. Merlo, F. Zilio, M. Vatrano, F. Bianco, M. Mancone, D. Zaffalon, A. Bonci, A. Boscutti, et al., “Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry,” Int. J. Cardiol., vol. 327, pp. 9–14, 2021. doi: 10.1016/j.ijcard.2020.11.040.
29. M. S. Tweet, S. N. Hayes, E. Codsi, R. Gulati, C. H. Rose, and P. J. M. Best, “Spontaneous coronary artery dissection associated with pregnancy,” J. Am. Coll. Cardiol., vol. 70, pp. 426–435, 2017. doi: 10.1016/j.jacc.2017.05.055.
30. A. Lerman, J. C. Burnett, S. T. Higano, L. J. McKinley, and D. R. Holmes, “Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans,” Circulation, vol. 97, pp. 2123–2128, 1998. doi: 10.1161/01.CIR.97.21.2123.
31. M. Alkhouli, M. Cole, and F. S. Ling, “Coronary artery fenestration prior to stenting in spontaneous coronary artery dissection,” Catheter. Cardiovasc. Interv., vol. 88, pp. E23–E27, 2016. doi: 10.1002/ccd.26161.
32. H. Wang, V. S. Pargaonkar, C. E. Hironaka, S. S. Bajaj, C. J. Abbot, C. T. O’Donnell, S. L. Miller, Y. Honda, I. S. Rogers, J. A. Tremmel, et al., “Off-pump minithoracotomy versus sternotomy for left anterior descending myocardial bridge unroofing,” Ann. Thorac. Surg., vol. 112, pp. 1474–1482, 2021. doi: 10.1016/j.athoracsur.2020.11.023.
33. C. Pacheco Claudio, O. Quesada, C. J. Pepine, and C. Noel Bairey Merz, “Why names matter for women: MINOCA/INOCA (myocardial infarction/ischemia and no obstructive coronary artery disease),” Clin. Cardiol., vol. 41, pp. 185–193, 2018. doi: 10.1002/clc.22894.
34. C. J. He, C. Y. Zhu, Y. J. Zhu, Z. X. Zou, S. J. Wang, C. L. Zhai, and H. L. Hu, “Effect of exercise-based cardiac rehabilitation on clinical outcomes in patients with myocardial infarction in the absence of obstructive coronary artery disease (MINOCA),” Int. J. Cardiol., vol. 315, pp. 9–14, 2020. doi: 10.1016/j.ijcard.2020.05.019.
35. K. R. Bainey, R. C. Welsh, W. Alemayehu, C. M. Westerhout, D. Traboulsi, T. Anderson, N. Brass, P. W. Armstrong, and P. Kaul, “Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): Insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study,” Int. J. Cardiol., vol. 264, pp. 12–17, 2018. doi: 10.1016/j.ijcard.2018.04.004.
36. V. Sucato, F. Comparato, A. Ortello, and A. R. Galassi, “Myocardial infarction with non-obstructive coronary arteries (MINOCA): Pathogenesis, diagnosis and treatment,” Curr. Probl. Cardiol., vol. 49, no. 7, p. 102583, 2024. doi: 10.1016/j.cpcardiol.2024.102583.
37. M. Zeng, C. Zhao, X. Bao, M. Liu, L. He, Y. Xu, W. Meng, Y. Qin, Z. Weng, B. Yi, D. Zhang, S. Wang, X. Luo, Y. Lv, X. Chen, Q. Sun, X. Feng, Z. Gao, Y. Sun, et al., “Clinical characteristics and prognosis of MINOCA caused by atherosclerotic and nonatherosclerotic mechanisms assessed by OCT,” JACC Cardiovasc. Imaging, vol. 16, no. 4, pp. 521–532, 2022. doi: 10.1016/j.jcmg.2022.10.023.
38. E. H. Choo, K. Chang, K. Y. Lee, D. Lee, J. G. Kim, Y. Ahn, Y. J. Kim, S. C. Chae, M. C. Cho, C. J. Kim, H. Kim, and M. H. Jeong, “Prognosis and predictors of mortality in patients suffering myocardial infarction with non-obstructive coronary arteries,” J. Am. Heart Assoc., vol. 8, no. 14, 2019. doi: 10.1161/jaha.119.011990.
39. G. Ciliberti, S. Coiro, I. Tritto, M. Benedetti, F. Guerra, M. Del Pinto, G. Finocchiaro, C. Cavallini, A. Capucci, J. C. Kaski, and G. Ambrosio, “Predictors of poor clinical outcomes in patients with acute myocardial infarction and non-obstructed coronary arteries (MINOCA),” Int. J. Cardiol., vol. 267, pp. 41–45, 2018. doi: 10.1016/j.ijcard.2018.03.092.
40. A. Andishmand, M. E. Meybodi, S. M. Namayandeh, H. R. Mohammadi, M. Andishmand, M. A. Zarbakhsh, and M. A. Zade, “Comparison between myocardial infarction with non-obstructive coronaries (MINOCA) and myocardial infarct patients with coronary artery disease (MI-CAD): A single-center retrospective cohort study,” Caspian J. Intern. Med., vol. 15, no. 1, pp. 109–114, 2024. doi: 10.22088/cjim.15.1.12.
41. N. Khorasani, Y. Mohammadi, M. Sarpoli, T. Kazemi, and S. M. Riahi, “Understanding myocardial infarction with non-obstructive coronary arteries (MINOCA): A comprehensive meta-analysis of clinical characteristics, management, and prognosis compared to MI with obstructive coronary artery (MIOCA),” BMC Cardiovasc. Disord., vol. 25, no. 1, 2025. doi: 10.1186/s12872-025-04504-2.
42. I. I. R. Candelario, A. E. Perez-Aybar, and J. A. Roman-Ramos, “MINOCA: A working diagnosis,” Cureus, 2023. doi: 10.7759/cureus.49695.
43. L. Ortega-Paz, M. Galli, D. Capodanno, S. Brugaletta, and D. J. Angiolillo, “The role of antiplatelet therapy in patients with MINOCA,” Front. Cardiovasc. Med., vol. 8, 2022. doi: 10.3389/fcvm.2021.821297.
44. K. Chan et al., "Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study," The Lancet, vol. 403, no. 10444, pp. 2606–2618, 2024. doi: 10.1016/S0140-6736(24)00596-8.
45. S. Edpuganti, A. Shamim, V. H. Gangolli, R. A. D. K. N. W. Weerasekara, and A. Yellamilli, “Artificial intelligence in cardiovascular imaging: Current landscape, clinical impact, and future directions,” Discoveries, vol. 13, no. 2, p. e211, 2025. doi: 10.15190/d.2025.10.